Serum zinc protoporphyrin and protoporphyrin IX levels as potential biomarkers for anti-tuberculosis drug-induced hepatotoxicity.

Publication date: Oct 01, 2026

Anti-tuberculosis drug-induced hepatotoxicity (ATDH) remains a significant clinical challenge, highlighting the critical demand for predictive biomarkers. This study aimed to investigate serum zinc protoporphyrin (ZnPP) and protoporphyrin IX (PPIX) as potential ATDH predictors. Blood samples were collected at baseline and two subsequent liver function tests in 58 cases and 191 controls from four hospitals. The ZnPP levels of controls at baseline and two subsequent time points (147. 9, 152. 0 and 147. 5 pg/ml, respectively) were significantly higher than cases (113. 1, 134. 3 and 119. 0 pg/ml), while the PPIX levels were significantly higher in ATDH cases (8. 6, 9. 4 and 9. 1 ng/ml, respectively) than controls (7. 0, 7. 6 and 7. 1 ng/ml) (P

Concepts Keywords
Adult
Anti-tuberculosis drug-induced hepatotoxicity
Antitubercular Agents
Antitubercular Agents
Biomarkers
Biomarkers
Case-Control Studies
Case-control study
Female
Humans
Liver Function Tests
Male
Middle Aged
protoporphyrin IX
Protoporphyrin IX
Protoporphyrins
Protoporphyrins
Risk Factors
zinc protoporphyrin
Zinc protoporphyrin

Semantics

Type Source Name
drug DRUGBANK Protoporphyrin
disease MESH Chemical and Drug Induced Liver Injury

Original Article

(Visited 6 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *